← DocG Medical Summaries

Top Psychiatry Research Papers

Live ranking — trailing 6 months, each paper's latest score Scores fold Psychiatry Relevance & Applicability into the quality dimensions; papers scored before the dynamic-specialty rubric keep their original score Showing the top 10 of 435 ranked articles — sign in free for the full ranking and per-criterion score breakdowns
1. 7.3
Adjunctive Antipsychotics in Major Depressive Disorder: A Systematic Review and Network Meta-Analysis.
Overall: A large, methodologically strong network meta-analysis offers useful short-term comparative guidance for a common condition, but absent absolute effects and limited maintenance evidence constrain its clinical impact.
2. 7.2
Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial.
Overall: This multisite US randomized trial found sustained but modest patient-important benefits from a more accessible CBT model, with meaningful scalability balanced by incomplete follow-up and ongoing coaching and technology requirements.
3. 7.2
Physical activity and perinatal depression and anxiety: a global umbrella review and meta-meta-analysis.
Overall: A rigorous umbrella review reports meaningful symptom improvement from accessible physical activity, but heterogeneity, limited anxiety evidence, absent safety and adherence data, and reliance on symptom scales temper its immediate practice-changing impact.
4. 7.0
Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.
Overall: This large US comparative-effectiveness study found a modest reduction in nonfatal overdose with buprenorphine-naloxone but no mortality advantage, providing clinically useful yet nonrandomized evidence for outpatient treatment selection after opioid withdrawal.
5. 7.0
Optimising and personalising task-shared psychosocial interventions for common mental disorders: a Bayesian component network meta-analysis of individual participant data.
Overall: A large, prespecified participant-level synthesis identifies potentially beneficial and detrimental therapy components, but uncertain clinical thresholds, durability, harms, and US implementation limit its immediate practice-changing force.
6. 6.9
A Digital Therapeutic Intervention for Negative Symptoms of Schizophrenia: A Randomized Clinical Trial.
Overall: A strong US randomized trial supports a safe, scalable digital adjunct with a modest benefit for negative symptoms, but broader patient-important effects and clinical significance remain uncertain.
7. 6.9
Clinical effectiveness of internet-delivered self-help Aacceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS): a multicentre, parallel, randomised controlled trial.
Overall: A well-conducted randomized trial found a moderate, clinically meaningful short-term reduction in caregiver anxiety with minimal reported harm and promising scalability, though attrition, limited follow-up, and the UK setting temper immediate US practice impact.
8. 6.9
Psychotherapy for Impact of Killing During War: A Randomized Clinical Trial.
Overall: A well-designed US randomized trial found a moderate functional benefit from a targeted psychotherapy, but mixed primary outcomes, modest sample size, and limited burden and implementation data temper its impact.
9. 6.9
Genotype-Guided Antidepressant Prescribing for Patients With Depression: A Randomized Clinical Trial.
Overall: This relevant US randomized trial found no short-term improvement from genotype-guided SSRI prescribing but identified a potentially meaningful secondary remission benefit at six months that requires further confirmation.
10. 6.9
Safety and effectiveness of strategies to deprescribe chronic benzodiazepine receptor agonist use in older adults: a systematic review.
Overall: This broadly relevant systematic review supports structured, gradual benzodiazepine receptor agonist deprescribing as feasible and generally safe, but heterogeneous evidence and absent quantitative effects limit certainty about patient-level benefit.
Score Guide: 9-10 Exceptional 7-8 Strong 5-6 Moderate 3-4 Weak 1-2 Poor

Get the top Psychiatry papers in your inbox

Free 300-word clinical summaries 3× per week, plus the full ranking of all 435 recent Psychiatry papers with per-criterion AI score breakdowns.

Sign Up Free